Request for Covid-19 Impact Assessment of this Report
The United States Cancer Ablation Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Ablation Devices market, reaching US$ million by the year 2028. As for the Europe Cancer Ablation Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cancer Ablation Devices players cover Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), and Biomedical S.r.l., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Ablation Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Cryoablation
High-Intensity Focused Ultrasound (HIFU)
Laser Interstitial Thermal Therapy (LiTT)
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Irreversible Electroporation (Ire)
Non-Thermal Ablation
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Brain Cancer
Brown
Colorectal Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Alfresa Pharma Corp.
AngioDynamics, Inc.
BTG plc (Galil Medical Ltd./Perseon Medical)
Biomedical S.r.l.
Boston Scientific Corporation
CSA Medical, Inc.
Chongqing Haifu Medical Technology Co., Ltd
ECO Medical
EDAP TMS S.A.
HS Hospital Service S.p.A.
IceCure Medical, Inc.
Johnson & Johnson (Ethicon, Inc.)
Kang-Yu Medical Co., Ltd.
MedLink Technologies LLC
MedWaves, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Ablation Devices Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cancer Ablation Devices by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cancer Ablation Devices by Country/Region, 2017, 2022 & 2028
2.2 Cancer Ablation Devices Segment by Type
2.2.1 Cryoablation
2.2.2 High-Intensity Focused Ultrasound (HIFU)
2.2.3 Laser Interstitial Thermal Therapy (LiTT)
2.2.4 Microwave Ablation (MWA)
2.2.5 Radiofrequency Ablation (RFA)
2.2.6 Irreversible Electroporation (Ire)
2.2.7 Non-Thermal Ablation
2.3 Cancer Ablation Devices Sales by Type
2.3.1 Global Cancer Ablation Devices Sales Market Share by Type (2017-2022)
2.3.2 Global Cancer Ablation Devices Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cancer Ablation Devices Sale Price by Type (2017-2022)
2.4 Cancer Ablation Devices Segment by Application
2.4.1 Brain Cancer
2.4.2 Brown
2.4.3 Colorectal Cancer
2.4.4 Kidney Cancer
2.4.5 Liver Cancer
2.4.6 Lung Cancer
2.4.7 Pancreatic Cancer
2.4.8 Prostate Cancer
2.5 Cancer Ablation Devices Sales by Application
2.5.1 Global Cancer Ablation Devices Sale Market Share by Application (2017-2022)
2.5.2 Global Cancer Ablation Devices Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cancer Ablation Devices Sale Price by Application (2017-2022)
3 Global Cancer Ablation Devices by Company
3.1 Global Cancer Ablation Devices Breakdown Data by Company
3.1.1 Global Cancer Ablation Devices Annual Sales by Company (2020-2022)
3.1.2 Global Cancer Ablation Devices Sales Market Share by Company (2020-2022)
3.2 Global Cancer Ablation Devices Annual Revenue by Company (2020-2022)
3.2.1 Global Cancer Ablation Devices Revenue by Company (2020-2022)
3.2.2 Global Cancer Ablation Devices Revenue Market Share by Company (2020-2022)
3.3 Global Cancer Ablation Devices Sale Price by Company
3.4 Key Manufacturers Cancer Ablation Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cancer Ablation Devices Product Location Distribution
3.4.2 Players Cancer Ablation Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cancer Ablation Devices by Geographic Region
4.1 World Historic Cancer Ablation Devices Market Size by Geographic Region (2017-2022)
4.1.1 Global Cancer Ablation Devices Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cancer Ablation Devices Annual Revenue by Geographic Region
4.2 World Historic Cancer Ablation Devices Market Size by Country/Region (2017-2022)
4.2.1 Global Cancer Ablation Devices Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cancer Ablation Devices Annual Revenue by Country/Region
4.3 Americas Cancer Ablation Devices Sales Growth
4.4 APAC Cancer Ablation Devices Sales Growth
4.5 Europe Cancer Ablation Devices Sales Growth
4.6 Middle East & Africa Cancer Ablation Devices Sales Growth
5 Americas
5.1 Americas Cancer Ablation Devices Sales by Country
5.1.1 Americas Cancer Ablation Devices Sales by Country (2017-2022)
5.1.2 Americas Cancer Ablation Devices Revenue by Country (2017-2022)
5.2 Americas Cancer Ablation Devices Sales by Type
5.3 Americas Cancer Ablation Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Ablation Devices Sales by Region
6.1.1 APAC Cancer Ablation Devices Sales by Region (2017-2022)
6.1.2 APAC Cancer Ablation Devices Revenue by Region (2017-2022)
6.2 APAC Cancer Ablation Devices Sales by Type
6.3 APAC Cancer Ablation Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cancer Ablation Devices by Country
7.1.1 Europe Cancer Ablation Devices Sales by Country (2017-2022)
7.1.2 Europe Cancer Ablation Devices Revenue by Country (2017-2022)
7.2 Europe Cancer Ablation Devices Sales by Type
7.3 Europe Cancer Ablation Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cancer Ablation Devices by Country
8.1.1 Middle East & Africa Cancer Ablation Devices Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cancer Ablation Devices Revenue by Country (2017-2022)
8.2 Middle East & Africa Cancer Ablation Devices Sales by Type
8.3 Middle East & Africa Cancer Ablation Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cancer Ablation Devices
10.3 Manufacturing Process Analysis of Cancer Ablation Devices
10.4 Industry Chain Structure of Cancer Ablation Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cancer Ablation Devices Distributors
11.3 Cancer Ablation Devices Customer
12 World Forecast Review for Cancer Ablation Devices by Geographic Region
12.1 Global Cancer Ablation Devices Market Size Forecast by Region
12.1.1 Global Cancer Ablation Devices Forecast by Region (2023-2028)
12.1.2 Global Cancer Ablation Devices Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cancer Ablation Devices Forecast by Type
12.7 Global Cancer Ablation Devices Forecast by Application
13 Key Players Analysis
13.1 Alfresa Pharma Corp.
13.1.1 Alfresa Pharma Corp. Company Information
13.1.2 Alfresa Pharma Corp. Cancer Ablation Devices Product Offered
13.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alfresa Pharma Corp. Main Business Overview
13.1.5 Alfresa Pharma Corp. Latest Developments
13.2 AngioDynamics, Inc.
13.2.1 AngioDynamics, Inc. Company Information
13.2.2 AngioDynamics, Inc. Cancer Ablation Devices Product Offered
13.2.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AngioDynamics, Inc. Main Business Overview
13.2.5 AngioDynamics, Inc. Latest Developments
13.3 BTG plc (Galil Medical Ltd./Perseon Medical)
13.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Company Information
13.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product Offered
13.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Main Business Overview
13.3.5 BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments
13.4 Biomedical S.r.l.
13.4.1 Biomedical S.r.l. Company Information
13.4.2 Biomedical S.r.l. Cancer Ablation Devices Product Offered
13.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biomedical S.r.l. Main Business Overview
13.4.5 Biomedical S.r.l. Latest Developments
13.5 Boston Scientific Corporation
13.5.1 Boston Scientific Corporation Company Information
13.5.2 Boston Scientific Corporation Cancer Ablation Devices Product Offered
13.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Boston Scientific Corporation Main Business Overview
13.5.5 Boston Scientific Corporation Latest Developments
13.6 CSA Medical, Inc.
13.6.1 CSA Medical, Inc. Company Information
13.6.2 CSA Medical, Inc. Cancer Ablation Devices Product Offered
13.6.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CSA Medical, Inc. Main Business Overview
13.6.5 CSA Medical, Inc. Latest Developments
13.7 Chongqing Haifu Medical Technology Co., Ltd
13.7.1 Chongqing Haifu Medical Technology Co., Ltd Company Information
13.7.2 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product Offered
13.7.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chongqing Haifu Medical Technology Co., Ltd Main Business Overview
13.7.5 Chongqing Haifu Medical Technology Co., Ltd Latest Developments
13.8 ECO Medical
13.8.1 ECO Medical Company Information
13.8.2 ECO Medical Cancer Ablation Devices Product Offered
13.8.3 ECO Medical Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ECO Medical Main Business Overview
13.8.5 ECO Medical Latest Developments
13.9 EDAP TMS S.A.
13.9.1 EDAP TMS S.A. Company Information
13.9.2 EDAP TMS S.A. Cancer Ablation Devices Product Offered
13.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 EDAP TMS S.A. Main Business Overview
13.9.5 EDAP TMS S.A. Latest Developments
13.10 HS Hospital Service S.p.A.
13.10.1 HS Hospital Service S.p.A. Company Information
13.10.2 HS Hospital Service S.p.A. Cancer Ablation Devices Product Offered
13.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 HS Hospital Service S.p.A. Main Business Overview
13.10.5 HS Hospital Service S.p.A. Latest Developments
13.11 IceCure Medical, Inc.
13.11.1 IceCure Medical, Inc. Company Information
13.11.2 IceCure Medical, Inc. Cancer Ablation Devices Product Offered
13.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 IceCure Medical, Inc. Main Business Overview
13.11.5 IceCure Medical, Inc. Latest Developments
13.12 Johnson & Johnson (Ethicon, Inc.)
13.12.1 Johnson & Johnson (Ethicon, Inc.) Company Information
13.12.2 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product Offered
13.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Johnson & Johnson (Ethicon, Inc.) Main Business Overview
13.12.5 Johnson & Johnson (Ethicon, Inc.) Latest Developments
13.13 Kang-Yu Medical Co., Ltd.
13.13.1 Kang-Yu Medical Co., Ltd. Company Information
13.13.2 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product Offered
13.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Kang-Yu Medical Co., Ltd. Main Business Overview
13.13.5 Kang-Yu Medical Co., Ltd. Latest Developments
13.14 MedLink Technologies LLC
13.14.1 MedLink Technologies LLC Company Information
13.14.2 MedLink Technologies LLC Cancer Ablation Devices Product Offered
13.14.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 MedLink Technologies LLC Main Business Overview
13.14.5 MedLink Technologies LLC Latest Developments
13.15 MedWaves, Inc.
13.15.1 MedWaves, Inc. Company Information
13.15.2 MedWaves, Inc. Cancer Ablation Devices Product Offered
13.15.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 MedWaves, Inc. Main Business Overview
13.15.5 MedWaves, Inc. Latest Developments
14 Research Findings and Conclusion
Table 1. Cancer Ablation Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cancer Ablation Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Cryoablation
Table 4. Major Players of High-Intensity Focused Ultrasound (HIFU)
Table 5. Major Players of Laser Interstitial Thermal Therapy (LiTT)
Table 6. Major Players of Microwave Ablation (MWA)
Table 7. Major Players of Radiofrequency Ablation (RFA)
Table 8. Major Players of Irreversible Electroporation (Ire)
Table 9. Major Players of Non-Thermal Ablation
Table 10. Global Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 11. Global Cancer Ablation Devices Sales Market Share by Type (2017-2022)
Table 12. Global Cancer Ablation Devices Revenue by Type (2017-2022) & ($ million)
Table 13. Global Cancer Ablation Devices Revenue Market Share by Type (2017-2022)
Table 14. Global Cancer Ablation Devices Sale Price by Type (2017-2022) & (US$/Unit)
Table 15. Global Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 16. Global Cancer Ablation Devices Sales Market Share by Application (2017-2022)
Table 17. Global Cancer Ablation Devices Revenue by Application (2017-2022)
Table 18. Global Cancer Ablation Devices Revenue Market Share by Application (2017-2022)
Table 19. Global Cancer Ablation Devices Sale Price by Application (2017-2022) & (US$/Unit)
Table 20. Global Cancer Ablation Devices Sales by Company (2020-2022) & (K Units)
Table 21. Global Cancer Ablation Devices Sales Market Share by Company (2020-2022)
Table 22. Global Cancer Ablation Devices Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Cancer Ablation Devices Revenue Market Share by Company (2020-2022)
Table 24. Global Cancer Ablation Devices Sale Price by Company (2020-2022) & (US$/Unit)
Table 25. Key Manufacturers Cancer Ablation Devices Producing Area Distribution and Sales Area
Table 26. Players Cancer Ablation Devices Products Offered
Table 27. Cancer Ablation Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Cancer Ablation Devices Sales by Geographic Region (2017-2022) & (K Units)
Table 31. Global Cancer Ablation Devices Sales Market Share Geographic Region (2017-2022)
Table 32. Global Cancer Ablation Devices Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Cancer Ablation Devices Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Cancer Ablation Devices Sales by Country/Region (2017-2022) & (K Units)
Table 35. Global Cancer Ablation Devices Sales Market Share by Country/Region (2017-2022)
Table 36. Global Cancer Ablation Devices Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Cancer Ablation Devices Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)
Table 39. Americas Cancer Ablation Devices Sales Market Share by Country (2017-2022)
Table 40. Americas Cancer Ablation Devices Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Cancer Ablation Devices Revenue Market Share by Country (2017-2022)
Table 42. Americas Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 43. Americas Cancer Ablation Devices Sales Market Share by Type (2017-2022)
Table 44. Americas Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 45. Americas Cancer Ablation Devices Sales Market Share by Application (2017-2022)
Table 46. APAC Cancer Ablation Devices Sales by Region (2017-2022) & (K Units)
Table 47. APAC Cancer Ablation Devices Sales Market Share by Region (2017-2022)
Table 48. APAC Cancer Ablation Devices Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Cancer Ablation Devices Revenue Market Share by Region (2017-2022)
Table 50. APAC Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 51. APAC Cancer Ablation Devices Sales Market Share by Type (2017-2022)
Table 52. APAC Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 53. APAC Cancer Ablation Devices Sales Market Share by Application (2017-2022)
Table 54. Europe Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)
Table 55. Europe Cancer Ablation Devices Sales Market Share by Country (2017-2022)
Table 56. Europe Cancer Ablation Devices Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Cancer Ablation Devices Revenue Market Share by Country (2017-2022)
Table 58. Europe Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 59. Europe Cancer Ablation Devices Sales Market Share by Type (2017-2022)
Table 60. Europe Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 61. Europe Cancer Ablation Devices Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)
Table 63. Middle East & Africa Cancer Ablation Devices Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Cancer Ablation Devices Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Cancer Ablation Devices Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Cancer Ablation Devices Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Cancer Ablation Devices Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Cancer Ablation Devices
Table 71. Key Market Challenges & Risks of Cancer Ablation Devices
Table 72. Key Industry Trends of Cancer Ablation Devices
Table 73. Cancer Ablation Devices Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Cancer Ablation Devices Distributors List
Table 76. Cancer Ablation Devices Customer List
Table 77. Global Cancer Ablation Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 78. Global Cancer Ablation Devices Sales Market Forecast by Region
Table 79. Global Cancer Ablation Devices Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Cancer Ablation Devices Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Cancer Ablation Devices Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Americas Cancer Ablation Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Cancer Ablation Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 84. APAC Cancer Ablation Devices Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Cancer Ablation Devices Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Europe Cancer Ablation Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Cancer Ablation Devices Sales Forecast by Country (2023-2028) & (K Units)
Table 88. Middle East & Africa Cancer Ablation Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Cancer Ablation Devices Sales Forecast by Type (2023-2028) & (K Units)
Table 90. Global Cancer Ablation Devices Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Cancer Ablation Devices Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Cancer Ablation Devices Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Cancer Ablation Devices Sales Forecast by Application (2023-2028) & (K Units)
Table 94. Global Cancer Ablation Devices Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Cancer Ablation Devices Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Cancer Ablation Devices Revenue Market Share Forecast by Application (2023-2028)
Table 97. Alfresa Pharma Corp. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Alfresa Pharma Corp. Cancer Ablation Devices Product Offered
Table 99. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Alfresa Pharma Corp. Main Business
Table 101. Alfresa Pharma Corp. Latest Developments
Table 102. AngioDynamics, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. AngioDynamics, Inc. Cancer Ablation Devices Product Offered
Table 104. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. AngioDynamics, Inc. Main Business
Table 106. AngioDynamics, Inc. Latest Developments
Table 107. BTG plc (Galil Medical Ltd./Perseon Medical) Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product Offered
Table 109. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. BTG plc (Galil Medical Ltd./Perseon Medical) Main Business
Table 111. BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments
Table 112. Biomedical S.r.l. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Biomedical S.r.l. Cancer Ablation Devices Product Offered
Table 114. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Biomedical S.r.l. Main Business
Table 116. Biomedical S.r.l. Latest Developments
Table 117. Boston Scientific Corporation Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. Boston Scientific Corporation Cancer Ablation Devices Product Offered
Table 119. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Boston Scientific Corporation Main Business
Table 121. Boston Scientific Corporation Latest Developments
Table 122. CSA Medical, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. CSA Medical, Inc. Cancer Ablation Devices Product Offered
Table 124. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CSA Medical, Inc. Main Business
Table 126. CSA Medical, Inc. Latest Developments
Table 127. Chongqing Haifu Medical Technology Co., Ltd Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 128. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product Offered
Table 129. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Chongqing Haifu Medical Technology Co., Ltd Main Business
Table 131. Chongqing Haifu Medical Technology Co., Ltd Latest Developments
Table 132. ECO Medical Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 133. ECO Medical Cancer Ablation Devices Product Offered
Table 134. ECO Medical Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. ECO Medical Main Business
Table 136. ECO Medical Latest Developments
Table 137. EDAP TMS S.A. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 138. EDAP TMS S.A. Cancer Ablation Devices Product Offered
Table 139. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. EDAP TMS S.A. Main Business
Table 141. EDAP TMS S.A. Latest Developments
Table 142. HS Hospital Service S.p.A. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 143. HS Hospital Service S.p.A. Cancer Ablation Devices Product Offered
Table 144. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. HS Hospital Service S.p.A. Main Business
Table 146. HS Hospital Service S.p.A. Latest Developments
Table 147. IceCure Medical, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 148. IceCure Medical, Inc. Cancer Ablation Devices Product Offered
Table 149. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. IceCure Medical, Inc. Main Business
Table 151. IceCure Medical, Inc. Latest Developments
Table 152. Johnson & Johnson (Ethicon, Inc.) Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 153. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product Offered
Table 154. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Johnson & Johnson (Ethicon, Inc.) Main Business
Table 156. Johnson & Johnson (Ethicon, Inc.) Latest Developments
Table 157. Kang-Yu Medical Co., Ltd. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 158. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product Offered
Table 159. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Kang-Yu Medical Co., Ltd. Main Business
Table 161. Kang-Yu Medical Co., Ltd. Latest Developments
Table 162. MedLink Technologies LLC Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 163. MedLink Technologies LLC Cancer Ablation Devices Product Offered
Table 164. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. MedLink Technologies LLC Main Business
Table 166. MedLink Technologies LLC Latest Developments
Table 167. MedWaves, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 168. MedWaves, Inc. Cancer Ablation Devices Product Offered
Table 169. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. MedWaves, Inc. Main Business
Table 171. MedWaves, Inc. Latest Developments
List of Figures
Figure 1. Picture of Cancer Ablation Devices
Figure 2. Cancer Ablation Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cancer Ablation Devices Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cancer Ablation Devices Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cancer Ablation Devices Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Cryoablation
Figure 10. Product Picture of High-Intensity Focused Ultrasound (HIFU)
Figure 11. Product Picture of Laser Interstitial Thermal Therapy (LiTT)
Figure 12. Product Picture of Microwave Ablation (MWA)
Figure 13. Product Picture of Radiofrequency Ablation (RFA)
Figure 14. Product Picture of Irreversible Electroporation (Ire)
Figure 15. Product Picture of Non-Thermal Ablation
Figure 16. Global Cancer Ablation Devices Sales Market Share by Type in 2021
Figure 17. Global Cancer Ablation Devices Revenue Market Share by Type (2017-2022)
Figure 18. Cancer Ablation Devices Consumed in Brain Cancer
Figure 19. Global Cancer Ablation Devices Market: Brain Cancer (2017-2022) & (K Units)
Figure 20. Cancer Ablation Devices Consumed in Brown
Figure 21. Global Cancer Ablation Devices Market: Brown (2017-2022) & (K Units)
Figure 22. Cancer Ablation Devices Consumed in Colorectal Cancer
Figure 23. Global Cancer Ablation Devices Market: Colorectal Cancer (2017-2022) & (K Units)
Figure 24. Cancer Ablation Devices Consumed in Kidney Cancer
Figure 25. Global Cancer Ablation Devices Market: Kidney Cancer (2017-2022) & (K Units)
Figure 26. Cancer Ablation Devices Consumed in Liver Cancer
Figure 27. Global Cancer Ablation Devices Market: Liver Cancer (2017-2022) & (K Units)
Figure 28. Cancer Ablation Devices Consumed in Lung Cancer
Figure 29. Global Cancer Ablation Devices Market: Lung Cancer (2017-2022) & (K Units)
Figure 30. Cancer Ablation Devices Consumed in Pancreatic Cancer
Figure 31. Global Cancer Ablation Devices Market: Pancreatic Cancer (2017-2022) & (K Units)
Figure 32. Cancer Ablation Devices Consumed in Prostate Cancer
Figure 33. Global Cancer Ablation Devices Market: Prostate Cancer (2017-2022) & (K Units)
Figure 34. Global Cancer Ablation Devices Sales Market Share by Application (2017-2022)
Figure 35. Global Cancer Ablation Devices Revenue Market Share by Application in 2021
Figure 36. Cancer Ablation Devices Revenue Market by Company in 2021 ($ Million)
Figure 37. Global Cancer Ablation Devices Revenue Market Share by Company in 2021
Figure 38. Global Cancer Ablation Devices Sales Market Share by Geographic Region (2017-2022)
Figure 39. Global Cancer Ablation Devices Revenue Market Share by Geographic Region in 2021
Figure 40. Global Cancer Ablation Devices Sales Market Share by Region (2017-2022)
Figure 41. Global Cancer Ablation Devices Revenue Market Share by Country/Region in 2021
Figure 42. Americas Cancer Ablation Devices Sales 2017-2022 (K Units)
Figure 43. Americas Cancer Ablation Devices Revenue 2017-2022 ($ Millions)
Figure 44. APAC Cancer Ablation Devices Sales 2017-2022 (K Units)
Figure 45. APAC Cancer Ablation Devices Revenue 2017-2022 ($ Millions)
Figure 46. Europe Cancer Ablation Devices Sales 2017-2022 (K Units)
Figure 47. Europe Cancer Ablation Devices Revenue 2017-2022 ($ Millions)
Figure 48. Middle East & Africa Cancer Ablation Devices Sales 2017-2022 (K Units)
Figure 49. Middle East & Africa Cancer Ablation Devices Revenue 2017-2022 ($ Millions)
Figure 50. Americas Cancer Ablation Devices Sales Market Share by Country in 2021
Figure 51. Americas Cancer Ablation Devices Revenue Market Share by Country in 2021
Figure 52. United States Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 53. Canada Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 54. Mexico Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 55. Brazil Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 56. APAC Cancer Ablation Devices Sales Market Share by Region in 2021
Figure 57. APAC Cancer Ablation Devices Revenue Market Share by Regions in 2021
Figure 58. China Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 59. Japan Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Korea Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 61. Southeast Asia Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 62. India Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 63. Australia Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 64. Europe Cancer Ablation Devices Sales Market Share by Country in 2021
Figure 65. Europe Cancer Ablation Devices Revenue Market Share by Country in 2021
Figure 66. Germany Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 67. France Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 68. UK Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 69. Italy Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 70. Russia Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 71. Middle East & Africa Cancer Ablation Devices Sales Market Share by Country in 2021
Figure 72. Middle East & Africa Cancer Ablation Devices Revenue Market Share by Country in 2021
Figure 73. Egypt Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 74. South Africa Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 75. Israel Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 76. Turkey Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 77. GCC Country Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Cancer Ablation Devices in 2021
Figure 79. Manufacturing Process Analysis of Cancer Ablation Devices
Figure 80. Industry Chain Structure of Cancer Ablation Devices
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...